Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Celularity (CELU) Cash from Investing Activities (2020 - 2024)

Historic Cash from Investing Activities for Celularity (CELU) over the last 5 years, with Q4 2024 value amounting to -$1.6 million.

  • Celularity's Cash from Investing Activities fell 17431.03% to -$1.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $514000.0, marking a year-over-year increase of 11269.76%. This contributed to the annual value of $514000.0 for FY2024, which is 11269.76% up from last year.
  • Latest data reveals that Celularity reported Cash from Investing Activities of -$1.6 million as of Q4 2024, which was down 17431.03% from $2.1 million recorded in Q2 2024.
  • Celularity's Cash from Investing Activities' 5-year high stood at $2.1 million during Q2 2024, with a 5-year trough of -$9.4 million in Q4 2020.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$1.1 million (2021), whereas its average is -$1.4 million.
  • In the last 5 years, Celularity's Cash from Investing Activities plummeted by 117563.64% in 2021 and then skyrocketed by 701612.9% in 2024.
  • Over the past 5 years, Celularity's Cash from Investing Activities (Quarter) stood at -$9.4 million in 2020, then soared by 75.43% to -$2.3 million in 2021, then skyrocketed by 66.17% to -$779000.0 in 2022, then rose by 25.55% to -$580000.0 in 2023, then tumbled by 174.31% to -$1.6 million in 2024.
  • Its last three reported values are -$1.6 million in Q4 2024, $2.1 million for Q2 2024, and -$39000.0 during Q1 2024.